• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients.

作者信息

Siami G A, Wilkins W T, Bess D T, Christman J W

机构信息

Vanderbilt University, Department of Veterans Affairs Medical Center, Nashville, Tennessee, USA.

出版信息

Drugs. 1995;49 Suppl 2:436-8. doi: 10.2165/00003495-199500492-00127.

DOI:10.2165/00003495-199500492-00127
PMID:8549392
Abstract
摘要

相似文献

1
Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients.环丙沙星与亚胺培南治疗老年住院患者重症肺炎的比较
Drugs. 1995;49 Suppl 2:436-8. doi: 10.2165/00003495-199500492-00127.
2
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.住院重症肺炎患者静脉滴注环丙沙星或亚胺培南治疗后继发感染的临床与经济学评价
J Antimicrob Chemother. 1999 Mar;43 Suppl A:129-34.
3
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.重症医院获得性肺炎的治疗：静脉用环丙沙星与亚胺培南/西司他丁的前瞻性随机对照研究
Thorax. 2000 Dec;55(12):1033-9. doi: 10.1136/thorax.55.12.1033.
4
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Drugs. 1995;49 Suppl 2:439-41. doi: 10.2165/00003495-199500492-00128.
5
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.环丙沙星加甲硝唑与亚胺培南-西司他丁治疗腹腔内感染的成本效益
Pharmacoeconomics. 1999 Nov;16(5 Pt 2):551-61. doi: 10.2165/00019053-199916050-00011.
6
[Comparison of ciprofloxacin with biapenem in patients with moderate or severe pneumonia].
Kansenshogaku Zasshi. 2007 May;81(3):276-83. doi: 10.11150/kansenshogakuzasshi1970.81.276.
7
Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.在接受亚胺培南治疗的患者中铜绿假单胞菌不同耐药机制的出现。
Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):731-2. doi: 10.1007/BF01690889.
8
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.左氧氟沙星单独或与亚胺培南或阿米卡星联合在鲍曼不动杆菌肺炎小鼠模型中的体内活性。
J Antimicrob Chemother. 2000 Nov;46(5):827-30. doi: 10.1093/jac/46.5.827.
9
Treatment of severe pneumonia with ciprofloxacin or imipenem.用环丙沙星或亚胺培南治疗重症肺炎。
Antimicrob Agents Chemother. 1994 Aug;38(8):1871-2. doi: 10.1128/AAC.38.8.1871.
10
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
Respiration. 1997;64(3):224-8. doi: 10.1159/000196675.

引用本文的文献

1
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.住院成人社区获得性肺炎非典型病原体的经验性抗生素覆盖。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD004418. doi: 10.1002/14651858.CD004418.pub4.
2
Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects.亚胺培南和美罗培南：体外活性、药代动力学、临床试验及不良反应的比较
Can J Infect Dis. 1998 Jul;9(4):215-28. doi: 10.1155/1998/831425.
3
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.

本文引用的文献

1
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.住院患者重症肺炎的治疗：一项比较静脉注射环丙沙星与亚胺培南 - 西司他丁的多中心、随机、双盲试验结果。重症肺炎研究组
Antimicrob Agents Chemother. 1994 Mar;38(3):547-57. doi: 10.1128/AAC.38.3.547.
2
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.环丙沙星与其他新型含氟哌嗪基取代喹啉衍生物的体外活性比较。
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21. doi: 10.1128/AAC.25.4.518.
3
肺炎铜绿假单胞菌的亚胺培南耐药性：系统文献回顾。
BMC Pulm Med. 2010 Aug 26;10:45. doi: 10.1186/1471-2466-10-45.
4
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.英国医院获得性肺炎管理指南：英国抗菌化疗协会医院获得性肺炎工作组报告
J Antimicrob Chemother. 2008 Jul;62(1):5-34. doi: 10.1093/jac/dkn162. Epub 2008 Apr 29.
The nationwide nosocomial infection rate. A new need for vital statistics.
全国医院感染率。对生命统计数据的新需求。
Am J Epidemiol. 1985 Feb;121(2):159-67. doi: 10.1093/oxfordjournals.aje.a113988.
4
Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
J Antimicrob Chemother. 1988 Oct;22(4):499-504. doi: 10.1093/jac/22.4.499.